The U.S. FDA has accused Canada Drugs -- an online Canadian pharmacy -- of selling unapproved, mislabeled and counterfeit drugs to doctors across the United States.
The online Winnipeg pharmacy is being accused of selling $78 million worth of unapproved, mislabeled cancer and chemo drugs, including counterfeit and unapproved versions of Roche's Avastin.
According to prosecutors, Canada Drugs’ affiliates bought non-FDA authorized or mislabeled drugs abroad, and then shipped them to the United States to sell to physicians at lower prices compared to the U.S. equivalents.
The U.S. grand jury returned an original indictment in November 2014, but the case in Montana federal court was under seal until this month, according to the Associated Press.
Read the AP release